NasdaqGS - Nasdaq Real Time Price USD
Ovid Therapeutics Inc. (OVID)
0.2860
-0.0160
(-5.30%)
At close: May 13 at 4:00:01 PM EDT
0.3185
+0.03
+(11.36%)
After hours: May 13 at 7:57:55 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 94,310 | 3 |
Sales | 9,181 | 2 |
Net Shares Purchased (Sold) | 85,129 | 5 |
Total Insider Shares Held | 11.58M | -- |
% Net Shares Purchased (Sold) | 0.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
RONA JEFFREY A Chief Financial Officer | Sale at price 0.56 per share. | Direct | 2,185 | Feb 26, 2025 |
ALEXANDER MARGARET A. President | Sale at price 0.56 per share. | Direct | 2,956 | Feb 26, 2025 |
RONA JEFFREY A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
ALEXANDER MARGARET A. President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
ALEXANDER MARGARET A. President | Purchase at price 0.73 per share. | Direct | 4,971 | Jan 27, 2025 |
LEVIN JEREMY M Chief Executive Officer | Purchase at price 2.76 per share. | Direct | 50,364 | Mar 18, 2024 |
RONA JEFFREY A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
PERONE THOMAS MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
TARDIO JASON Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
LEVIN JEREMY M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 4, 2023 |
Related Tickers
PASG Passage Bio, Inc.
0.2950
-4.31%
MRSN Mersana Therapeutics, Inc.
0.3582
-0.67%
LYEL Lyell Immunopharma, Inc.
0.4046
-4.03%
KZR Kezar Life Sciences, Inc.
4.2000
-0.71%
APGE Apogee Therapeutics, Inc.
39.74
+0.40%
SNSE Sensei Biotherapeutics, Inc.
0.3564
-1.76%
DSGN Design Therapeutics, Inc.
3.5700
-1.38%
TSBX Turnstone Biologics Corp.
0.3400
+1.77%
CGEM Cullinan Therapeutics, Inc.
7.62
-3.67%
NGNE Neurogene Inc.
15.51
-12.37%